Localized Breast Cancer 2025 UPDATE

This week’s episode we have a very special guest, friend and colleague Dr. Laura Vater joining us to talk about one of the biggest transitions in medicine—moving from fellow to attending.Dr Vater is a GI oncologist at IU, writer, and speaker. She focuses on the dignity of patient ... Show More

This week’s episode will be focusing on an ASCO 2026 Plenary abstract, SARC 041. SARC041 is the first positive phase 3 randomized controlled trial of a CDK4/6 inhibitor in advanced dedifferentiated liposarcoma (DDLPS), demonstrating that abemaciclib significantly improves progres ... Show More

Today we are recapping exciting GU data presented at the 2026 ASCO Annual Meeting in bladder cancer, kidney cancer, and prostate cancer. 

Get ready for an insightful conversation in the second episode of Wellness Matters by American Hospital Dubai! We dive into how oncoplastic surgery, paired with cutting-edge seed technology, is transforming breast cancer treatment. This advancement is making tumor detection more ... Show More

In this episode, Dr Parveen Boora discusses breast cancer. Topics covered include: approach to the history and physical exam of breast masses indications for breast imaging and biopsy staging invasive cancer management of breast cancer surgery for primary tumors surgery for axill ... Show More

Breast cancer is one of the most studied and high-profile cancers, and yet we still have so much to learn. While we have come such a long way and so many lives have been saved by advances in research, there’s still some breast cancers that are aggressive and don’t respond to trea ... Show More

Wellness Matters | Breast Cancer Detection: Why Every Angle Matters Join us for Episode 3 of the Wellness Matters: Pink Edition by American Hospital Dubai! In this episode, we dive into the vital topic of breast cancer detection and discuss why examining it from every angle is cr ... Show More

Dr. Angela DeMichele, Dr. Lynn Henry, and Dr. Harold Burstein present the latest breast cancer rapid recommendation update impacting two ASCO guidelines. This update focuses on the new option, capivasertib plus fulvestrant, for patients with hormone receptor-positive, HER2-negati ... Show More

Join Drs Kevin Kalinsky and Jennifer Litton as they discuss hereditary breast cancer, genetic testing, and therapeutic implications. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/991258). The topics and discussions ... Show More

Dr. Chino talks with Dr. Atif Khan and Dr. Lola Fayanju about the shift in breast cancer management from reducing locoregional recurrence and improving breast cancer mortality to deintensification, shared decision making, and improved quality of life. This discussion will be base ... Show More

<p>Our second SABCS (San Antonio Breast Cancer Symposium) episode covers everything (else) you need to know from 2024. </p><br><p>In this episode, we dive into the role of trastuzumab deruxtecan in HR +ve, HER2 low cancers, perioperative atezolizumab in tnbc, the use of a novel A ... Show More

In this episode, we’ll be discussing biologic and other targeted therapies in gyn oncology, including indications and management of toxicities. Join us for bi-weekly episodes or check out our episode archive and show notes at readysetgyo.com. Follow us on Instagram @ReadySetGYOPo ... Show More

<p>Before immunotherapy, targeted chemotherapy (ADCs) and precision oncology, there was endocrine therapy, the forefather (or mother) of effective treatment to reduce breast cancer recurrence as well as delay disease progression. This episode dives into a past of phenomenal impro ... Show More